Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Return on Invested Capital (2016 - 2025)

Ani Pharmaceuticals' Return on Invested Capital history spans 13 years, with the latest figure at 0.11% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 11.0% year-over-year to 0.11%; the TTM value through Dec 2025 reached 0.11%, up 11.0%, while the annual FY2025 figure was 0.11%, 11.0% up from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.11% at Ani Pharmaceuticals, roughly flat from 0.11% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.17% in Q4 2023 and bottomed at 0.18% in Q3 2022.
  • The 5-year median for Return on Invested Capital is 0.01% (2024), against an average of 0.0%.
  • The largest annual shift saw Return on Invested Capital rose 30bps in 2023 before it dropped -17bps in 2024.
  • A 5-year view of Return on Invested Capital shows it stood at 0.07% in 2021, then plummeted by -100bps to 0.13% in 2022, then surged by 229bps to 0.17% in 2023, then crashed by -99bps to 0.0% in 2024, then surged by 11374bps to 0.11% in 2025.
  • Per Business Quant, the three most recent readings for ANIP's Return on Invested Capital are 0.11% (Q4 2025), 0.11% (Q3 2025), and 0.04% (Q2 2025).